Sponsor or institution
Clinical trials and research at Atom Therapeutics Co., Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Atom Therapeutics Co., Ltd that are recruiting, at sites in 3 countries (most in Australia (2), China (2), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
ABP-671 in people with chronic kidney disease and high uric acid
This phase 2 trial tests ABP-671 (with or without febuxostat) to see if it helps people with CKD and high uric acid.
-
ABP-745 to reduce atherosclerotic plaque in people with ASCVD
This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.
Quick answers
How many clinical trials run by Atom Therapeutics Co., Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (2 trials), China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.